Tag: Diabetes: Type II
Metabolomics Signature Can Predict GDM to T2DM Transition
Metabolomics with baseline fasting plasma could predict transition from gestational diabetes to T2DM
Glucagon-Like Peptide-1 Receptor Agonists Beneficial As Add-On
Reduction in HbA1c with both lixisenatide, glulisine; less hypoglycemia with lixisenatide
Metabolomics Signature Can Predict GDM to T2DM Transition
Metabolomics with baseline fasting plasma could predict transition from gestational diabetes to T2DM
Metabolomics Signature Can Predict GDM to T2DM Transition
Metabolomics with baseline fasting plasma could predict transition from gestational diabetes to T2DM
Butter May Not Be As Unhealthy As Previously Thought
Researchers find little added health danger for those who consume butter
Gastric Bypass Helps Achieve Diabetes Treatment Goals
Lower mean HbA1c, more diabetes remission, more weight loss versus lifestyle-medical management
Too Little, Too Much Sleep Can Impair Insulin Sensitivity in Men
However, similar association not found in women
Liraglutide Tops Lixisenatide As Add-On to Metformin in T2DM
Greater reduction in hemoglobin A1c, greater reduction in fasting plasma glucose with liraglutide
Novel Lipid Mediators May Play Role in Omega-3 PUFA Effects
Novel mediators involved in beneficial effects attributed to omega-3 PUFA in obesity
50 Percent Insulin Lispro/Insulin Lispro Protamine Efficacious
More effective than LM25 in certain dietary conditions, including with increased carbohydrate
